A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

July 31, 2026

Conditions

Solid TumorsGastric CancerEsophagogastric Juction CancerColorectal Cancer

Interventions

DRUG

JR8603

IV infusion on Days 1, 8, and 15 of continuous 28-day cycles

Trial Locations (2)

RECRUITING

Liaoning Cancer Hospital, Shenyang

RECRUITING

Harbin Medical University Cancer Hospital, Harbin

All Listed Sponsors

lead

JiaRay Group

INDUSTRY